Julian “Jay” Hinesley III, MHA, President of Vanderbilt Wilson County Hospital (VWCH), is leaving his role with Vanderbilt University Medical Center to join the Medical University of South Carolina (MUSC) as Chief Executive Officer for MUSC Health’s Florence Division in Florence, South Carolina, where he will lead three hospitals located in Florence and adjacent communities. He will depart VWCH and VUMC on April 30.

Lance Gregory wanted the message to be visible from the windows of Children's Hospital — in memory of his brother Cory

Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy.

Laura Kennedy, MD, PhD, has joined Vanderbilt University Medical Center from the University of Washington School of Medicine/Fred Hutchinson Cancer Research Center in Seattle where she was acting instructor and research associate.

Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.

Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level.

Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.